| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0002 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.23 | 0.0005 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |